| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Regulation FD Disclosure
Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakers |
| 15 Oct 2026 |
8-K: Regulation FD Disclosure
Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa |
| 02 Oct 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation (“ASPI” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among ENDRA Life Sciences Inc., a Delaware corp... |
| 08 Sep 2026 |
8-K: Regulation FD Disclosure
DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts i... |
| 20 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
and counter-signed by ASP Isotopes South Africa Proprietary Limited (as subordinated creditor under the Subordination Agreement) for the purpose of giving the assurances and confirmations in Clause 5 (Further assurances) of this Agreement |
| 20 Aug 2026 |
8-K: Regulation FD Disclosure
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa |
| 18 Aug 2026 |
8-K: Regulation FD Disclosure
DALLAS, August 18, 2026 – ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and process... |
| 06 Aug 2026 |
8-K: Regulation FD Disclosure
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa |
| 05 Aug 2026 |
8-K: Regulation FD Disclosure
DALLAS, August 05, 2026 -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple indus... |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DALLAS, August 4, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical material... |
| 30 Jul 2026 |
8-K: Regulation FD Disclosure
DALLAS, July 30, 2026 -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industr... |
| 28 Jul 2026 |
8-K: Regulation FD Disclosure
DALLAS, July 28, 2026 — ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industri... |
| 21 Jul 2026 |
8-K: Regulation FD Disclosure
ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology |
| 16 Jul 2026 |
8-K: Other Events
ASP Isotopes Inc. (“we,” “our,” “us,” or “ASPI”) is filing this Exhibit 99.1 to its Current Report on Form 8-K (the “Form 8-K”) solely to retrospectively recast certain financial information and related disclosures included in our Annual... |
| 16 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
This Securities Exchange Agreement (this “Agreement”), dated as of July 15, 2026 (the “Effective Date”), is entered into by and between ASP Isotopes Inc., a Delaware corporation (the “Company”), Quantum Leap Energy LLC, a Delaware limite... |
| 25 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
This AGREEMENT AND PLAN OF MERGER is made and entered into as of June 25, 2026 (this “Agreement”), by and among ASP Isotopes Inc., a Delaware corporation (“Parent”), Noble Africa LLC, a Delaware limited liability company and a direct, su... |
| 25 Jun 2026 |
8-K: Regulation FD Disclosure
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing |
| 23 Jun 2026 |
8-K: Regulation FD Disclosure
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into its first take-or-pay contract to supply contained helium to an Asian industrial gases company, establishing a multi-year contracted cash fl... |
| 26 May 2026 |
8-K: Regulation FD Disclosure
ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026 |
| 20 May 2026 |
8-K: Regulation FD Disclosure
On May 20, 2026, ASP Isotopes Inc. (the “Company”) released its latest investor presentation (the “Presentation”). The Presentation is available on the Company’s website, www.aspisotopes.com, on the Home page. All of the information in t... |
Loading...